Recorded Chinese product: 羟苯磺酸钙分散片羟苯磺酸钙分散片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

羟苯磺酸钙是一种在国家药监局注册认定的药品。该药品含有羟苯磺酸钙-158cdb94等成分。

该药品关联的活性成分包括:羟苯磺酸钙Qiangben Huangsuan Gai。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:江苏万高药业有限公司Chinese legal name: 江苏万高药业有限公司。

您可以探索含有相同成分的其他药品:羟苯磺酸钙-158cdb94成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 羟苯磺酸钙分散片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 羟苯磺酸钙Qiangben Huangsuan Gai.

Manufacturers recorded for this product: 江苏万高药业有限公司Chinese legal name: 江苏万高药业有限公司.

Explore other medicines containing the same ingredient: 羟苯磺酸钙 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 羟苯磺酸钙分散片Recorded Chinese product: 羟苯磺酸钙分散片
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 0.25g*36片0.25 g × 36 tablets

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 江苏万高药业有限公司Chinese legal name: 江苏万高药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20080288

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20080288

Manufacturer

Chinese legal name: 江苏万高药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

0.25 g × 36 tablets

中文说明书原文Original Chinese source label

批准文号

国药准字H20080288

生产企业

江苏万高药业有限公司(国产)

适应症

主要用于糖尿病引起的视网膜病变和肾小球性硬化症。也用于微循环障碍引起的各种静脉曲张和痔疮、溃疡腿、瘙痒性皮炎等。

用法用量

进餐时口服,部分症状推荐指导剂量如下(或遵医嘱): 1.糖尿病性视网模病变:一次0.5g(2片),一日3次,疗程为4―6月。进一步治疗,每日1.0g(4片)以维持疗效。 2.其它微血管病:一次0.5g(2片),一日3次,疗程为1―2月。进一步治疗,每日1.0g(4片)直至症状消失。 3.静脉曲张综合症及静脉功能不全 一次0.5g(2片),一日2次,疗程为1―3周。治疗5―6天即见疗效,以后每日服0.5g~1.0g(2-4片)以巩固疗效。

不良反应

本品即使长期服用也耐受良好,但不能排除过敏反应。罕见病例,尤在大剂量时可有胃部不适、恶心、胃灼热及厌食。这些病例应酌情减量,必要时停药。

禁忌

对制剂中的任何成分过敏者禁用。

注意事项

1.置于安全和儿童不能拿到的地方。
2.怀孕首3个月妇女不推荐使用本品。

贮藏

密封,于阴凉(不超过20℃)干燥处保存。

规格

0.25g*36片

证据Evidence

  • 批准文号: 国药准字H20080288
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.